NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
- Status
- RECRUITING
- Phase
- N/A
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AOH1996 for the Treatment of Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Video Education With Result Dependent dIsclosure
- Status
- RECRUITING
- Phase
- NA
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
- Status
- COMPLETED
- Phase
- N/A
APX005M in Patients With Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2